Can long COVID cause thoracic (chest) pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, Long COVID Can Cause Thoracic (Chest) Pain

Long COVID definitively causes thoracic/chest pain, with reported prevalence ranging from 10-44% of cases, particularly common at 4-12 weeks post-infection 1. This is a well-recognized cardiovascular manifestation of post-acute sequelae of SARS-CoV-2 infection (PASC).

Prevalence and Timing

Chest pain represents one of the most frequently reported cardiovascular symptoms in long COVID:

  • 10-44% of long COVID patients experience chest pain or chest discomfort 1
  • Symptoms are particularly common at 4-12 weeks following acute infection 1
  • Can persist for 12+ months in some patients 2
  • Occurs across all severity levels of initial COVID-19 infection, including mild cases 2

Multiple Underlying Mechanisms

The 2022 ACC Expert Consensus 2 identifies several potential etiologies for chest pain in long COVID:

Cardiovascular Causes (PASC-CVD):

  • Myopericarditis - inflammation of heart muscle and/or pericardium 1
  • Endothelial dysfunction - vascular injury from direct viral infection or immune response 2
  • Coronary vasospasm - abnormal endothelial-dependent responses found in 82% of tested PASC patients with angina 2
  • Microvascular dysfunction - affecting small coronary vessels 2
  • Myocardial ischemia - reduced blood flow to heart muscle 1

Non-Cardiac Causes:

  • Pulmonary complications - pneumonia, pulmonary embolism, pleuritic pain 2
  • POTS (Postural Orthostatic Tachycardia Syndrome) - chest pain is a common feature 2
  • ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - chest pain component with poorly understood mechanisms 2

Recommended Evaluation Approach

When a patient presents with persistent chest pain after COVID-19, the Canadian Cardiovascular Society 1 and ACC 2 recommend:

Initial Testing ("Triad Testing"):

  1. ECG - looking for diffuse T-wave inversion, ST-segment elevation, QRS prolongation
  2. Cardiac troponin (cTn) - elevated above 99th percentile indicates myocardial injury
  3. Echocardiography - assess for wall motion abnormalities, ventricular dysfunction, pericardial effusion

Additional Investigations Based on Findings:

  • Cardiac MRI - if troponin elevated or echo abnormal; most sensitive for detecting myocarditis, inflammation, nonischemic scar 1, 2
  • Functional testing for ischemia - if ischemic heart disease suspected 1
  • Ambulatory rhythm monitoring - if palpitations or arrhythmia suspected 2
  • Chest imaging and pulmonary function tests - to exclude pulmonary causes 2

Critical Clinical Distinction

The ACC guidelines 2 make an important distinction:

  • PASC-CVD = Chest pain with objective cardiovascular disease detected on testing (myocarditis, ischemia, etc.)
  • PASC-CVS = Chest pain with normal or non-diagnostic testing but persistent symptoms

Both are legitimate manifestations of long COVID, but management differs. PASC-CVS patients may benefit from empiric therapies including beta-blockers, calcium channel blockers, or ivabradine 2.

When to Refer to Cardiology

Cardiology consultation is recommended for patients with 2:

  1. Abnormal cardiac test results
  2. Known cardiovascular disease with new/worsening symptoms
  3. Documented cardiac complications during acute SARS-CoV-2 infection
  4. Persistent cardiopulmonary symptoms not otherwise explained

Common Pitfalls to Avoid

  • Don't dismiss chest pain in patients with mild initial COVID-19 - debilitating PASC symptoms occur even after asymptomatic or mild infection 2
  • Don't assume normal initial testing rules out cardiac involvement - some patients develop symptoms weeks to months later 2
  • Don't overlook vasospasm - recent evidence shows this is a significant contributor, found in 82% of PASC patients with angina undergoing invasive testing 2
  • Don't forget non-cardiac causes - pulmonary embolism, pneumonia, and dysautonomia can all present with chest pain 2

Management Considerations

For symptomatic patients with chest pain:

  • If myocarditis confirmed: hospitalize if unstable; outpatient management with activity restriction (3-6 months) if stable 2
  • If PASC-CVS (normal testing): consider empiric medical therapy with beta-blockers, ivabradine, or other agents; initiate graded recumbent exercise (rowing, swimming, cycling) starting at 5-10 minutes/day 2
  • Avoid upright exercise initially in patients with orthostatic intolerance or tachycardia 2

The evidence consistently demonstrates that thoracic pain is a legitimate, common, and multifactorial manifestation of long COVID requiring systematic evaluation to identify treatable causes while providing symptomatic management when testing is unrevealing.

References

Related Questions

What are the typical persistent symptoms of long COVID and the recommended evaluation and management?
Are roller coaster rides safe or beneficial for individuals with Long COVID?
How does long COVID affect sleep?
Is post‑COVID condition (long COVID) recognized as a medical diagnosis?
In a patient with a history of lung cancer who has been short of breath for two weeks and now has COVID-19 with elevated liver function tests, can Paxlovid (nirmatrelvir/ritonavir) be administered?
In a patient with suspected unstable angina, should coronary computed tomography angiography (CTA) or stress testing be used as the initial diagnostic test?
Can a healthy 5‑year‑old child receive the diphtheria‑pertussis‑tetanus (DPT) vaccine and the injectable typhoid polysaccharide (Vi) vaccine concurrently?
In a pediatric patient with a facial or neck rash that spreads downward and becomes desquamating, without a murmur, what is the most likely diagnosis: Kawasaki disease, fifth disease (erythema infectiosum), rubella, or measles?
Could a stroke be responsible for the observed pinpoint pupils and gasping respirations?
How should an adult woman presenting with localized breast pain without a palpable mass be evaluated and managed?
What are the key breast symptoms that should be asked about during an outpatient department (OPD) evaluation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.